- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today the receipt of an award on June 5th from the Iowa Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) program for the "Most Successful Commercialization Result of an SBIR/STTR Funded Project." Since 2002, BioForce has received three SBIR awards totaling $1.3 million, which funded portions of the development of the Nano eNabler™ molecular printer and the SPT™ print cartridges it uses.
BioForce's Founder and CEO, Dr. Eric Henderson accepted the award and says, "BioForce Nanosciences is grateful for our success with the SBIR/STTR grant program, especially that administered by the National Institutes of Health. The SBIR funding has been a tremendous boost to BioForce's product commercialization success. The success is reflected by the Company's 200 percent employee growth during 2006 and BioForce's highest revenues ever in the first quarter of 2007."
The Nano eNabler system dispenses very small drops of liquid onto surfaces with precision and speed. With this innovative surface patterning tool, BioForce offers scientists a practical solution to problems they encounter when developing ultra miniaturized bioanalytical and biomedical devices. The print cartridges used by the Nano eNabler™ system, or surface patterning tools (SPT™), give the Nano eNabler system its unique qualities at the benefit of scientists in many disciplines. SPT print cartridges can have single or multiple print heads for simultaneous printing of a variety of molecular species or materials.
About BioForce Nanosciences, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. For more information, visit http://www.bioforcenano.com.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company’s most recent filings with the Securities and Exchange Commission. The Company’s actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
For more information, please click here
RedChip Companies Inc.
Robert Rehse, 1-800-REDCHIP (733-2447) ext 111
BioForce Nanosciences, Inc.
Deb Happe, 515-233-8333, Ext. 123
Director of Communications
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
One step closer to a single-molecule device: Columbia Engineering researchers first to create a single-molecule diode -- the ultimate in miniaturization for electronic devices -- with potential for real-world applications May 25th, 2015
What makes cancer cells spread? New device offers clues May 19th, 2015